These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

431 related articles for article (PubMed ID: 18666213)

  • 1. Agent Orange exposure, Vietnam War veterans, and the risk of prostate cancer.
    Chamie K; DeVere White RW; Lee D; Ok JH; Ellison LM
    Cancer; 2008 Nov; 113(9):2464-70. PubMed ID: 18666213
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prostate cancer detection in veterans with a history of Agent Orange exposure.
    Zafar MB; Terris MK
    J Urol; 2001 Jul; 166(1):100-3. PubMed ID: 11435832
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prostate cancer control and survival in Vietnam veterans exposed to Agent Orange.
    Everly L; Merrick GS; Allen ZA; Butler WM; Wallner K; Lief JH; Galbreath RW; Adamovich E
    Brachytherapy; 2009; 8(1):57-62. PubMed ID: 18955017
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Editorial comment on: Agent Orange exposure, Vietnam War veterans, and the risk of prostate cancer.
    Shah SR; Terris MK
    Cancer; 2008 Nov; 113(9):2382-4. PubMed ID: 18661514
    [No Abstract]   [Full Text] [Related]  

  • 5. Agent Orange and long-term outcomes after radical prostatectomy.
    Ovadia AE; Terris MK; Aronson WJ; Kane CJ; Amling CL; Cooperberg MR; Freedland SJ; Abern MR
    Urol Oncol; 2015 Jul; 33(7):329.e1-6. PubMed ID: 25998746
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between Agent Orange and prostate cancer: a pilot case-control study.
    Giri VN; Cassidy AE; Beebe-Dimmer J; Ellis L; Smith DC; Bock CH; Cooney KA
    Urology; 2004 Apr; 63(4):757-60; discussion 760-1. PubMed ID: 15072895
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Agent Orange: management of patients exposed in Vietnam.
    Beaulieu A; Fessele K
    Clin J Oncol Nurs; 2003; 7(3):320-3. PubMed ID: 12793339
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Agent orange exposure and prostate cancer risk in the million veteran program.
    Pagadala MS; Lui AJ; Zhong AY; Lynch JA; Karunamuni R; Lee KM; Plym A; Rose BS; Carter HK; Kibel AS; DuVall SL; Gaziano JM; Panizzon MS; Hauger RL; Seibert TM
    Acta Oncol; 2024 May; 63():373-378. PubMed ID: 38779869
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A critical review of the epidemiology of Agent Orange/TCDD and prostate cancer.
    Chang ET; Boffetta P; Adami HO; Cole P; Mandel JS
    Eur J Epidemiol; 2014 Oct; 29(10):667-723. PubMed ID: 25064616
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exposure to Agent Orange is a significant predictor of prostate-specific antigen (PSA)-based recurrence and a rapid PSA doubling time after radical prostatectomy.
    Shah SR; Freedland SJ; Aronson WJ; Kane CJ; Presti JC; Amling CL; Terris MK
    BJU Int; 2009 May; 103(9):1168-72. PubMed ID: 19298411
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High level of dioxin-TEQ in tissue is associated with Agent Orange exposure but not with biochemical recurrence after radical prostatectomy.
    Li Q; Lan L; Klaassen Z; Shah SR; Moses KA; Terris MK
    Prostate Cancer Prostatic Dis; 2013 Dec; 16(4):376-81. PubMed ID: 24018710
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Agent Orange as a risk factor for high-grade prostate cancer.
    Ansbaugh N; Shannon J; Mori M; Farris PE; Garzotto M
    Cancer; 2013 Jul; 119(13):2399-404. PubMed ID: 23670242
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urologic cancer risks for veterans exposed to Agent Orange.
    Hoenemeyer LA
    Urol Nurs; 2013; 33(2):87-90, 99. PubMed ID: 23734554
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Agent Orange Exposure and Monoclonal Gammopathy of Undetermined Significance: An Operation Ranch Hand Veteran Cohort Study.
    Landgren O; Shim YK; Michalek J; Costello R; Burton D; Ketchum N; Calvo KR; Caporaso N; Raveche E; Middleton D; Marti G; Vogt RF
    JAMA Oncol; 2015 Nov; 1(8):1061-8. PubMed ID: 26335650
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exposure to Agent Orange is associated with increased recurrence after surgical treatment of stage I non-small cell lung cancer.
    Subramanian MP; Eaton DB; Labilles UL; Heiden BT; Chang SH; Yan Y; Schoen MW; Patel MR; Kreisel D; Nava RG; Thomas TS; Meyers BF; Kozower BD; Puri V
    J Thorac Cardiovasc Surg; 2024 May; 167(5):1591-1600.e2. PubMed ID: 37709166
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prostate cancer in US Air Force veterans of the Vietnam war.
    Pavuk M; Michalek JE; Ketchum NS
    J Expo Sci Environ Epidemiol; 2006 Mar; 16(2):184-90. PubMed ID: 16047038
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exposure to Agent Orange and Risk of Bladder Cancer Among US Veterans.
    Williams SB; Janes JL; Howard LE; Yang R; De Hoedt AM; Baillargeon JG; Kuo YF; Tyler DS; Terris MK; Freedland SJ
    JAMA Netw Open; 2023 Jun; 6(6):e2320593. PubMed ID: 37368398
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Agent Orange exposure and cancer incidence in Korean Vietnam veterans: a prospective cohort study.
    Yi SW; Ohrr H
    Cancer; 2014 Dec; 120(23):3699-706. PubMed ID: 25103108
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Agent Orange exposure, Vietnam war veterans, and the risk of prostate cancer.
    Schecter A; Needham L; Pavuk M; Michalek J; Colacino J; Ryan J; Päpke O; Birnbaum L
    Cancer; 2009 Jul; 115(14):3369-71. PubMed ID: 19415730
    [No Abstract]   [Full Text] [Related]  

  • 20. Agent Orange, prostate cancer irradiation and acute promyelocyic leukemia (APL): is there a link?
    Atallah E; Schiffer CA
    Leuk Res; 2007 May; 31(5):720-1. PubMed ID: 16956658
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 22.